BKBrendan T. Keenan

Brendan T. Keenan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Brendan T. Keenan has a total of 196 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Physiologic mechanisms of response to hypoglossal nerve stimulation

    by Linda C Magaña, Yash Dixit, Bruno Saconi, Brendan T Keenan, Everett G Seay, Alan R Schwartz, Raj C Dedhia

    Study Objectives: To evaluate the relationship between physiologic mechanisms under drug-induced sleep endoscopy (DISE) and polysomnographic response to hypoglossal nerve stimulation (HGNS). Materials and Methods: In an NIH-funded interventional trial, 30 subjects with HGNS devices underwent DISE with pneumotachometer, pharyngeal manometry, and positive airway pressure titration. On the previous night, subjects underwent a split-night polysomnogram (first portion without HGNS and second at a single clinically-determined voltage) in the supine position. Responder status was determined by a 50% reduction in supine apnea–hypopnea index (AHI). Groups (responders vs. nonresponders) were compared using the Wilcoxon Rank Sum Test, and Spearman’s rho was used to assess correlations between physiologic mechanisms under DISE and polysomnographic response. Results: Patients (n = 30) were generally older (64.3 ± 8.9 years), female (56.7%), and overweight (body mass index 28.1 ± 3.1 kg/m2) with severe obstructive sleep apnea (supine AHI 47.7 ± 25.4 events/hour). Among 14 responders and 16 nonresponders, there was no statistical difference in baseline collapsibility (pharyngeal opening pressure, 5.9 ± 2.4 vs 7.2 ± 3.7 cmH2O, p = 0.39) or baseline inspiratory epiglottic pressure (Pepi, − 17.2 ± 9.0 vs − 18.6 ± 12.8 cmH2O, p = 0.99). Improvements in collapsibility (rho = 0.70, p = 0.0001) and inspiratory Pepi (rho = −0.70, p = 0.0001) with HGNS were strongly associated with reduction in supine AHI. Conclusions: In this small interventional study, decreases in collapsibility and effort during DISE are markers of clinical response to HGNS therapy. Our novel findings demonstrate responses to acute physiologic interventions during DISE translate to natural sleep outcomes. Clinical Trial: “Characterizing Mechanisms of Upper Airway Obstruction During Drug-Induced Sleep Endoscopy (DISE)”, https://clinicaltrials.gov/study/NCT04322097, Registration No: NCT04322097

  • Open Access

    Sleepiness and attention in sleep-clinic patients and their associations with apnea severity and treatment

    by Allison Schwab, Brendan T Keenan, Nathan C Nowalk, Mathias Basner, Charles J Bae

    Study Objectives: Excessive daytime sleepiness (EDS) is common in patients with sleep disorders, particularly obstructive sleep apnea (OSA). The Epworth Sleepiness Scale (ESS) and the Psychomotor Vigilance Test (PVT) are often used to measure sleepiness and attention/vigilance, respectively. However, whether these measures are correlated and their relationship to OSA severity/treatment remains understudied. This study examined these associations in a sleep center population. Methods: We performed a prospective study of 165 participants (119 [72.1%] with diagnosed OSA) presenting to a sleep disorders clinic and completing ESS and PVT. Associations among ESS, PVT, OSA severity, and positive airway pressure (PAP) usage and efficacy were examined using Pearson’s correlations, unadjusted and controlling for age, sex, and body mass index. Results: Results showed no significant correlations between ESS and PVT measures of attention/vigilance. While higher ESS scores correlated with more severe apnea–hypopnea indices in patients with OSA, no association was found with OSA severity and PVT measures. Among participants using PAP, greater hours/night of usage was associated with lower ESS scores, but not with better PVT performance. Conclusions: We found no association between sleepiness on the ESS and attention/vigilance on PVT among a sleep center population. ESS scores tracked more closely to OSA severity/treatment than PVT measures. The findings suggest that the sleepiness measured by the ESS and measures of sustained attention under monotonous conditions from the PVT capture distinct symptoms. While the ESS is commonly used, further research is needed to determine if the PVT should also be incorporated into clinical practice.


  • Generalizability of symptom-based subtypes of moderate to severe obstructive sleep apnea patients within and between ethnic groups

    by Huijie Yi, Jingjing Guo, Brendan T Keenan, Diego R Mazzotti, Philip de Chazal, Ning-Hung Chen, Peter A Cistulli, Thorarinn Gislason, Samuel T Kuna, Qing Yun Li, et al.

    Rationale: Multiple studies have shown that symptom-based subtypes of obstructive sleep apnea (OSA) exist and are generalizable to clinical and population-based samples of different race/ethnic and regional backgrounds. However, there have not been studies evaluating the generalizability within a clinical sample of Chinese ancestry. Objectives: The aim of the current study was to investigate the generalizability of symptom-based subtypes within clinical patients from China. Methods: This is a cross-sectional, multicenter study of patients with OSA from international sleep centers participating in the Sleep Apnea Global Interdisciplinary Consortium (SAGIC). Two Chinese cohorts were collected: 666 patients from Peking University People’s Hospital (PKUPH) and 503 patients from other China sites (Peking University International Hospital, Taiwan, and Shanghai). In addition, 694 White patients were included from 7 sites across 5 countries (Iceland, Germany [Berlin], Australia [Sydney, Perth], Brazil, and the United States [Ohio State University and University of Pennsylvania]). Symptom-based subtypes were determined using a latent class analysis (LCA) of 18 self-reported symptom variables and 3 comorbidities. Results: A total of 1863 patients were included in the LCA. The previously described 5 symptom subtypes (disturbed sleep, minimal symptoms, excessively sleepy, moderately sleepy, and upper airway symptoms dominant) were optimal in the PKUPH site, other China sites, and White patients from SAGIC. Chinese patients had higher prevalence of the minimal symptoms subtype (P < .001) compared to White patients. Among the 5 subtypes, the excessively sleepy subtype exhibited the highest apnea–hypopnea index and oxygen desaturation index. Conclusions: Based on the included symptoms and comorbidities, 5 subtypes provided the optimal groupings across Chinese and White patients in SAGIC. Chinese patients were more likely to present with fewer symptoms. These data further enhance understanding of the generalizability of OSA symptom subtypes across ethnically diverse backgrounds and pave the way for precision management of OSA in the future.


  • More correlates – not predictors – of hypoglossal nerve stimulation effectiveness

    by Raj C. Dedhia, Brendan T. Keenan

    Extract Hypoglossal nerve stimulation (HGNS) continues to gain clinical momentum, with >100 000 Inspire implants worldwide and US Food and Drug Administration approval of a second system, Nyxoah's Genio implant last month following successful trial results [1]. Despite this momentum, efficacy remains suboptimal, with up to 50% of implanted real-world patients demonstrating inadequate response [2–4]. Hence, pre-operative “predictors” of success continue to tantalise clinicians and researchers alike. Shareable abstract Prediction of surgical outcomes remains a top priority for nascent fields, such as hypoglossal nerve stimulation; however, findings of association are not necessarily findings of prediction https://bit.ly/475pDZ4

  • Weight loss in older adults with obstructive sleep apnea: beneficial or harmful?

    by Nathan C Nowalk, Brendan T Keenan, Babak Mokhlesi, Richard J Schwab

  • The Relationship between Upper Airway Anatomy and Obesity in Patients with Obstructive Sleep Apnea

    by Liyue Xu, Brendan T. Keenan, Andrew S. Wiemken, Bethany Staley, Bryndis Benediktsdottir, Sigurdur Juliusson, Allan I. Pack, Thorarinn Gislason, Richard J. Schwab

    Rationale: Obesity is the most important risk factor for obstructive sleep apnea (OSA). However, the complex relationship between obesity and upper airway anatomy (craniofacial structure, soft tissues, and airway caliber) has not been robustly examined in patients with OSA. Objectives: To evaluate the relationship between obesity, on the basis of body mass index (BMI), and upper airway anatomic structures in adult patients with moderate or severe OSA. Methods: In this cross-sectional study, 583 patients with apnea–hypopnea index ≥15 events/h (mean age, 53.7 ± 10.4 yr; 81.0% men) were included from the Iceland Sleep Apnea Cohort. Airway sizes, soft tissue volumes, and craniofacial dimensions were quantified using three-dimensional magnetic resonance imaging. We examined how upper airway anatomy was associated with BMI using linear regression (continuous BMI) and analysis of covariance (BMI categories), adjusting for age, sex, and apnea–hypopnea index. Results: Most upper airway anatomy was significantly associated with BMI among patients with OSA. Higher BMI was associated with a different airway shape, including larger minimum anteroposterior distance at both the retropalatal and retroglossal regions and smaller minimum lateral distance in the retropalatal region. All pharyngeal soft tissues were larger with greater BMI, including the volumes of the tongue (and tongue fat), soft palate (and soft palate fat), lateral walls, fat pads, epiglottis, and pterygoids. Patients with lower BMIs had smaller craniofacial measures (e.g., distances between hyoid, retropogonion, and third cervical vertebrae, intramandibular volume, and nasooropharyngeal areas) and more retrognathia. BMI was only weakly associated with the proportion of mandibular space occupied by soft tissues (with no difference among BMI groups), suggesting comparable intraoral “crowdedness” among patients with OSA at different degrees of obesity, albeit for different reasons. Conclusions: The present results support associations between obesity and airway shape, soft tissue volumes, and craniofacial measures among patients with moderate to severe OSA. These relationships provide insights into anatomic traits leading to OSA in lean and obese patients and can inform more personalized treatment options.


  • Open Access

    The AASM sleep staging paradigm gains data-driven support

    by Brendan T Keenan, Ulysses J Magalang

  • Top Cited Papers
    Open Access

    Research Priorities for Translating Endophenotyping of Adult Obstructive Sleep Apnea to the Clinic: An Official American Thoracic Society Research Statement

    by Thomas M. Tolbert, Christopher N. Schmickl, Laura K. Gell, Brendan T. Keenan, Diego R. Mazzotti, Sara Op de Beeck, Amal M. Osman, Cinthya Peña-Orbea, Scott A. Sands, Tamar Sofer, et al.

    Background: Obstructive sleep apnea (OSA) pathogenesis, clinical manifestations, and consequences vary markedly among patients. Yet OSA heterogeneity goes largely unaddressed in current management pathways, which are characterized by high treatment failure rates of ∼50%. Growing knowledge of OSA pathogenesis has stimulated new lines of investigation for therapies targeted to specific underlying mechanisms or “endotypes.” OSA endotypes include the primary anatomic predisposition to pharyngeal collapse, as well as “nonanatomic” mechanisms of low arousal threshold, unstable control of breathing (high loop gain), and impaired pharyngeal dilator muscle function. Identification of interindividual differences in OSA endotypes and disease expression, or “OSA phenotypes,” offers promise for a more targeted approach to OSA management in which appropriate treatments are tailored to individual needs. However, these concepts have largely been limited to the research setting, and more evidence is needed to support clinical translation. Goals: To outline the rationale for clinical use, challenges, and key research priorities required to translate OSA endophenotyping for delivery of a more tailored approach to improve patient care and outcomes. Methods: An international multidisciplinary working group with expertise in OSA epidemiology, pathophysiology, diagnostics, and treatments was convened. The group met at the American Thoracic Society 2024 International Conference to discuss the current state of OSA endophenotyping and required research objectives. This research statement, authored with input from all members, summarizes the group discussion, identified key areas, and research priorities. Results: The working group identified research priorities that cover the spectrum from discovery to translation/implementation, including technical standards, validation, establishment of clinical cutoffs and minimal clinically important differences, generalizability across diverse populations, stability and reproducibility of measurement, prospective study design and conduct, clinical utility, and impact analysis. Conclusions: This research statement provides a road map of the opportunities and key steps required to generate the evidence necessary to translate OSA endophenotyping concepts into clinical care at scale.


  • Open Access

    Psychomotor Vigilance Test and Epworth Sleepiness Scale in Participants being Evaluated for Sleep Disorders

    by Allison Schwab, Brendan T. Keenan, Mathias Basner, Charles J. Bae

    Study Objectives Excessive daytime sleepiness (EDS) is common in participants with sleep disorders, particularly obstructive sleep apnea (OSA), and can be assessed using the Epworth Sleepiness Scale (ESS) and the Psychomotor Vigilance Test (PVT). However, the relationship between these measures of sleepiness/attention, and their relationships to OSA severity and treatment, remains understudied. This study examined these associations in a sleep center population. Methods A total of 167 participants, primarily diagnosed or suspected of OSA (n=128 [76.6%]), completed the ESS and PVT during their clinical visit. Associations among ESS, PVT, OSA severity and CPAP adherence were examined using Pearson’s correlations, unadjusted and controlling for age, sex and body mass index. Results Results showed no significant correlations between ESS and PVT measures of attention/vigilance. While higher ESS scores correlated with more severe apnea-hypopnea index (AHI) in participants with OSA, no association was found with PVT measures. Among participants using continuous positive airway pressure (CPAP), greater hours/night of usage was associated with lower ESS scores, but not with better PVT performance. Conclusions Our data indicate that ESS scores track more closely than PVT to OSA severity and treatment. The findings suggest that the tendency to fall asleep as measured by the ESS and attention deficits on PVT may capture different aspects of “sleepiness”. While the ESS is commonly used in sleep clinics, further research is needed to determine if PVT should also be used routinely in clinical practice. Brief summary Excessive daytime sleepiness (EDS) is a prevalent symptom among individuals with obstructive sleep apnea (OSA), but the relationship between a subjective measure (Epworth Sleepiness Scale) and an objective measure (Psychomotor Vigilance Test) of sleepiness or attention, as well as how each relates to OSA severity and treatment, is not well understood. This study found no association between the ESS and measures from a 3-minute PVT, suggesting that these assessments are not evaluating the same aspects of “sleepiness” reported by participants. Higher ESS scores, but not worse PVT performance, was related to more severe OSA and less adherence to CPAP, indicating that the ESS tracks more closely than the PVT to OSA severity and treatment use.